Advus Financial Partners, LLC’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Sell
1,882
-12
-0.6% -$2.49K 0.1% 146
2026
Q1
$400K Buy
1,894
+47
+3% +$10.1K 0.1% 146
2025
Q4
$380K Sell
1,847
-501
-21% -$94.3K 0.09% 158
2025
Q3
$369K Sell
2,348
-15
-0.6% -$2.32K 0.09% 166
2025
Q2
$397K Sell
2,363
-15
-0.6% -$2.23K 0.1% 142
2025
Q1
$328K Buy
2,378
+17
+0.7% +$2.17K 0.09% 161
2024
Q4
$279K Buy
2,361
+21
+0.9% +$2.45K 0.08% 177
2024
Q3
$259K Sell
2,340
-171
-7% -$17.9K 0.07% 185
2024
Q2
$247K Sell
2,511
-465
-16% -$47.4K 0.08% 176
2024
Q1
$333K Sell
2,976
-379
-11% -$40.9K 0.1% 129
2023
Q4
$338K Buy
3,355
+12
+0.4% +$1.19K 0.12% 113
2023
Q3
$290K Buy
3,343
+41
+1% +$3.71K 0.11% 106
2023
Q2
$312K Buy
+3,302
New +$279K 0.12% 103

Other funds holding CAH

Advus Financial Partners, LLC's CAH Position: Q2 2026 in Review

Advus Financial Partners, LLC reduced its Cardinal Health (CAH) stake by 0.63% in Q2 2026, selling an estimated $2.49K and leaving 1,882 shares worth $447K. The position accounts for 0.1% of the portfolio, ranked #146.

Advus Financial Partners, LLC first reported a position in CAH in Q2 2023 and has held it in 13 quarters since. 1,494 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Advus Financial Partners, LLC held 1,882 shares of Cardinal Health worth $447K as of Q2 2026.
  • Advus Financial Partners, LLC sold 12 Cardinal Health shares in Q2 2026, an estimated $2.49K.
  • Cardinal Health made up 0.1% of Advus Financial Partners, LLC's portfolio in Q2 2026, its #146 holding.
  • Advus Financial Partners, LLC first reported a position in Cardinal Health in Q2 2023 and has held it in 13 quarters since.
  • 1,494 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Advus Financial Partners, LLC's 13F filing for Q2 2026, filed 25 Aug 2026.